Daiwa Securities analyst Narumi Nakagiri upgraded Merck (NYSE: MRK) from Neutral (3) to Outperform (2) with a price target of $143.00 (from $120.00).

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $130.42 yesterday.